tiprankstipranks
Trending News
More News >
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market

Bafna Pharmaceuticals Limited (BAFNAPH) Financial Statements

Compare
0 Followers

Bafna Pharmaceuticals Limited Financial Overview

Bafna Pharmaceuticals Limited's market cap is currently ₹3.31B. The company's EPS TTM is ₹1.321; its P/E ratio is 35.87; Bafna Pharmaceuticals Limited is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 1.46B₹ 1.52B₹ 1.15B₹ 851.40M₹ 712.18M
Gross Profit₹ 168.77M₹ 452.15M₹ 387.56M₹ 338.60M₹ 257.62M
Operating Income₹ 62.87M₹ 237.66M₹ 103.92M₹ 64.98M₹ 58.55M
EBITDA₹ 117.73M₹ 146.34M₹ 189.88M₹ 112.34M₹ 103.94M
Net Income₹ 41.52M₹ 73.48M₹ 113.38M₹ 52.16M₹ 58.27M
Balance Sheet
Cash & Short-Term Investments₹ 34.33M₹ 13.96M₹ 78.09M₹ 194.00K₹ 18.04M
Total Assets₹ 1.53B₹ 1.48B₹ 1.30B₹ 901.45M₹ 864.66M
Total Debt₹ 281.99M₹ 243.89M₹ 229.24M₹ 110.59M₹ 130.00M
Net Debt₹ 247.66M₹ 229.93M₹ 151.14M₹ 110.40M₹ 111.96M
Total Liabilities₹ 682.73M₹ 668.43M₹ 561.29M₹ 281.81M₹ 296.95M
Stockholders' Equity₹ 848.07M₹ 808.39M₹ 734.55M₹ 619.64M₹ 567.71M
Cash Flow
Free Cash Flow₹ -23.31M₹ -60.93M₹ -32.66M₹ 21.87M₹ -197.04M
Operating Cash Flow₹ 195.29M₹ 94.85M₹ 49.52M₹ 97.28M₹ -136.09M
Investing Cash Flow₹ -213.02M₹ -150.54M₹ -74.93M₹ -65.44M₹ -53.45M
Financing Cash Flow₹ 38.09M₹ -8.45M₹ 101.77M₹ -48.15M₹ 122.80M
Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History

Bafna Pharmaceuticals Limited Debt to Assets

Bafna Pharmaceuticals Limited Cash Flow

Bafna Pharmaceuticals Limited Forecast EPS vs Actual EPS